US EditionCheap, generic and unpatentable DMSO: A THREAT to Big Pharma profits
Summary by Dr. Eddy Bettermann MD
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Cheap, generic and unpatentable DMSO: A THREAT to Big Pharma profits
DMSO (dimethyl sulfoxide) is a versatile, low-cost solvent with remarkable medicinal properties, including pain relief, anti-inflammatory effects and drug delivery. Despite over 11,000 studies supporting its benefits, it remains largely sidelined in mainstream medicine due to its unpatentable, generic nature. Discovered in 1866, DMSO can penetrate skin, muscle and bone, delivering drugs systemically. Beyond transport, it reduces swelling, soften…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
